Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on French STEM Today.
Press releases published on July 7, 2025
AMAX Introduces Liquid-Cooled 64-GPU Rack for AI Training and Inference at Scale
EIN Presswire
·
July 7, 2025
The LiquidMax® RackScale 64 offers a fully integrated rack with 8 liquid-cooled B200 servers, built for advanced AI infrastructure in production environments. Amax Holding Co., Ltd. (TWSE:(6933.TW)) FREMONT, CA, UNITED STATES, July 7, 2025 /EINPresswire …
NANOBIOTIX Announces Regulatory Harmonization and New Composition of Matter Patent Filed for JNJ-1900 (NBTXR3)
GlobeNewswire
·
July 7, 2025
Health authorities in major European countries have accepted the reclassification of JNJ-1900 (NBTXR3) from a medical device to a medicinal product, aligning with regulatory status in the US and other major markets Medicinal product classification supports …
NANOBIOTIX annonce une harmonisation réglementaire et le dépôt d’une demande d’un nouveau brevet de composition de matière pour JNJ-1900 (NBTXR3)
GlobeNewswire
·
July 7, 2025
Les autorités de santé des principaux pays européens ont accepté la reclassification de JNJ-1900 (NBTXR3) en tant que médicament, au lieu de dispositif médical, alignant ainsi son statut réglementaire sur celui en vigueur aux États-Unis et dans d'autres …
Monaco.com: The Principality’s Crown Jewel Domain Now Available for Acquisition
EIN Presswire
·
July 7, 2025
One-word .COM digitally unlocks the Principality’s €50-billion-a-year luxury ecosystem and the highest-net-worth audience on the planet. SCOTTSDALE, AZ, UNITED STATES, July 7, 2025 /EINPresswire.com/ -- Premium domain broker Fred Mercaldo today …
First patient dosed in the Phase I clinical trial of PulseSight Therapeutics’ PST-611 treatment for dry AMD/Geographic Atrophy
GlobeNewswire
·
July 7, 2025
PARIS, July 07, 2025 (GLOBE NEWSWIRE) -- PulseSight Therapeutics SAS, an ophthalmology biotech company developing disruptive non-viral vectorized therapies with minimally-invasive delivery technology, is pleased to announce that the first patient has been …